U.S. market Closed. Opens in 13 hours 46 minutes

DNTH | Dianthus Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue2.83M6.42M1.48MN/AN/AN/AN/AN/A
Cost of Revenue355.00K147.00K2.02M1.98M1.84M875.00K376.00K6.00K
Gross Profit2.47M6.27M-544.00K-1.98M-1.84M-875.00K-376.00K-6.00K
Operating Expenses51.00M36.12M14.56M76.72M81.13M59.09M35.35M9.26M
Selling, General & Admin18.16M6.74M1.96M28.09M23.76M17.75M7.45M3.48M
Research & Development32.84M29.38M12.61M48.64M57.37M41.34M27.90M5.78M
Other Operating ExpensesN/A-52.00KN/AN/AN/AN/AN/AN/A
Operating Income-48.17M-29.70M-13.09M-78.70M-82.97M-59.96M-35.73M-9.27M
Other Expenses / Income4.62M1.23M-23.00K3.77M6.20M2.45M236.00K-163.00K
Before Tax Income-43.55M-28.48M-13.11M-74.94M-76.77M-57.52M-35.49M-9.43M
Income Tax ExpensesN/A-1.28M-2.00M7.53M6.20M2.45M236.00KN/A
Net Income-43.55M-28.48M-13.11M-74.94M-76.77M-57.52M-35.49M-9.43M
Interest ExpensesN/AN/A3.56M3.77MN/AN/AN/A163.00K
Basic Shares Outstanding5.15M3.75M3.43M2.75M2.31M1.15M2.21M2.21M
Diluted Shares Outstanding5.15M3.75M3.43M2.75M2.31M1.15M2.21M2.21M
EBITDA-48.17M-29.56M-13.09M-72.96M-74.93M-56.64M-35.12M-9.26M
EBITDA Margin-1,704.67%-460.62%-886.59%0.00%0.00%0.00%0.00%0.00%
EBIT-43.55M-29.76M-11.55M-63.64M-70.57M-55.07M-35.26M-9.27M
EBIT Margin-1,541.22%-463.72%-782.52%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙